Correlation of Smoking-Associated DNA Methylation Changes in Buccal Cells With DNA Methylation Changes in Epithelial Cancer.

IMPORTANCE The utility of buccal cells as an epithelial source tissue for epigenome-wide association studies (EWASs) remains to be demonstrated. Given the direct exposure of buccal cells to potent carcinogens such as smoke, epigenetic changes in these cells may provide insights into the development of smoke-related cancers. OBJECTIVE To perform an EWAS in buccal and blood cells to assess the relative effect of smoking on the DNA methylation (DNAme) patterns in these cell types and to test whether these DNAme changes are also seen in epithelial cancer. DESIGN, SETTING, AND PARTICIPANTS In 2013, we measured DNAme at more than 480,000 CpG sites in buccal samples provided in 1999 by 790 women (all aged 53 years in 1999) from the United Kingdom Medical Research Council National Survey of Health and Development. This included matched blood samples from 152 women. We constructed a DNAme-based smoking index and tested its sensitivity and specificity to discriminate normal from cancer tissue in more than 5000 samples. MAIN OUTCOMES AND MEASURES CpG sites whose DNAme level correlates with smoking pack-years, and construction of an associated sample-specific smoking index, which measures the mean deviation of DNAme at smoking-associated CpG sites from a normal reference. RESULTS In a discovery set of 400 women, we identified 1501 smoking-associated CpG sites at a genome-wide significance level of P < 10-7, which were validated in an independent set of 390 women. This represented a 40-fold increase of differentially methylated sites in buccal cells compared with matched blood samples. Hypermethylated sites were enriched for bivalently marked genes and binding sites of transcription factors implicated in DNA repair and chromatin architecture (P < 10-10). A smoking index constructed from the DNAme changes in buccal cells was able to discriminate normal tissue from cancer tissue with a mean receiver operating characteristic area under the curve of 0.99 (range, 0.99-1.00) for lung cancers and of 0.91 (range, 0.71-1.00) for 13 other organs. The corresponding area under the curve of a smoking signature derived from blood cells was lower than that derived from buccal cells in 14 of 15 cancer types (Wilcoxon signed rank test, P = .001). CONCLUSIONS AND RELEVANCE These data point toward buccal cells as being a more appropriate source of tissue than blood to conduct EWASs for smoking-related epithelial cancers.

[1]  Francesco Marabita,et al.  A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data , 2012, Bioinform..

[2]  Herbert Schulz,et al.  RAD21 Cooperates with Pluripotency Transcription Factors in the Maintenance of Embryonic Stem Cell Identity , 2011, PloS one.

[3]  Nianxiang Zhang,et al.  Widespread and Tissue Specific Age-related Dna Methylation Material Supplemental Related Content a Hallmark of Cancer Age-dependent Dna Methylation of Genes That Are Suppressed in Stem Cells Is , 2022 .

[4]  R. Peto,et al.  Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys , 2012, The Lancet.

[5]  Zdenka Pausova,et al.  Cigarette smoking and DNA methylation , 2013, Front. Genet..

[6]  D. Balding,et al.  Epigenome-wide association studies for common human diseases , 2011, Nature Reviews Genetics.

[7]  Prabhat Jha,et al.  21st-century hazards of smoking and benefits of cessation in the United States. , 2013, The New England journal of medicine.

[8]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.

[9]  D. Odom,et al.  CTCF and Cohesin: Linking Gene Regulatory Elements with Their Targets , 2013, Cell.

[10]  Mei Sun,et al.  Establishment of primary mouse lung adenocarcinoma cell culture. , 2011, Oncology letters.

[11]  D. Rickman,et al.  Prediction of future metastasis and molecular characterization of head and neck squamous-cell carcinoma based on transcriptome and genome analysis by microarrays , 2008, Oncogene.

[12]  R. Peto,et al.  Global effects of smoking, of quitting, and of taxing tobacco. , 2014, The New England journal of medicine.

[13]  M. Esteller,et al.  Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome , 2011, Epigenetics.

[14]  A. McCullough Comprehensive genomic characterization of squamous cell lung cancers , 2013 .

[15]  Paolo Vineis,et al.  Epigenome-wide association study in the European Prospective Investigation into Cancer and Nutrition (EPIC-Turin) identifies novel genetic loci associated with smoking. , 2013, Human molecular genetics.

[16]  Anna Berg,et al.  Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene , 2014, Oncotarget.

[17]  D. Kuh,et al.  Cohort Profile: The 1946 National Birth Cohort (MRC National Survey of Health and Development). , 2006, International journal of epidemiology.

[18]  H. Kitchener,et al.  The Dynamics and Prognostic Potential of DNA Methylation Changes at Stem Cell Gene Loci in Women's Cancer , 2012, PLoS genetics.

[19]  A. Oshlack,et al.  SWAN: Subset-quantile Within Array Normalization for Illumina Infinium HumanMethylation450 BeadChips , 2012, Genome Biology.

[20]  Nicolò Riggi,et al.  EZH2 is essential for glioblastoma cancer stem cell maintenance. , 2009, Cancer research.

[21]  R. Peto,et al.  Differences among the coloured, white, black, and other South African populations in smoking-attributed mortality at ages 35–74 years: a case-control study of 481 640 deaths , 2013, The Lancet.

[22]  A. Sakurada,et al.  Microarray analysis of promoter methylation in lung cancers , 2006, Journal of Human Genetics.

[23]  G. Colditz,et al.  Smoking and the risk of endometrial cancer: Results from the Nurses' Health Study , 2005, International journal of cancer.

[24]  S. Baylin,et al.  Aging and DNA methylation in colorectal mucosa and cancer. , 1998, Cancer research.

[25]  Marcus Richards,et al.  Cohort Profile: Updating the cohort profile for the MRC National Survey of Health and Development: a new clinic-based data collection for ageing research , 2011, International journal of epidemiology.

[26]  H. Kitchener,et al.  Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation , 2012, Genome Medicine.

[27]  Michael Q. Zhang,et al.  DNA methylation data analysis and its application to cancer research. , 2013, Epigenomics.

[28]  Christian Gieger,et al.  Tobacco Smoking Leads to Extensive Genome-Wide Changes in DNA Methylation , 2013, PloS one.

[29]  P. Laird,et al.  Epigenetic stem cell signature in cancer , 2007, Nature Genetics.

[30]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Å. Johansson,et al.  Smoke-related DNA methylation changes in the etiology of human disease. , 2014, Human molecular genetics.

[32]  Andrew E. Teschendorff,et al.  Age-associated epigenetic drift: implications, and a case of epigenetic thrift? , 2013, Human molecular genetics.

[33]  Per Magne Ueland,et al.  DNA Methylation as a Long-term Biomarker of Exposure to Tobacco Smoke , 2013, Epidemiology.

[34]  M. Thun,et al.  Active smoking and breast cancer risk: original cohort data and meta-analysis. , 2013, Journal of the National Cancer Institute.

[35]  N. Ahuja,et al.  Accelerated age-related CpG island methylation in ulcerative colitis. , 2001, Cancer research.

[36]  Andrew E. Teschendorff,et al.  Role of DNA Methylation and Epigenetic Silencing of HAND2 in Endometrial Cancer Development , 2013, PLoS medicine.

[37]  Bernhard Korn,et al.  Tobacco-smoking-related differential DNA methylation: 27K discovery and replication. , 2011, American journal of human genetics.

[38]  A. Feinberg,et al.  The epigenetic progenitor origin of human cancer , 2006, Nature Reviews Genetics.

[39]  E. Hurt,et al.  EZH2 Is Required for Breast and Pancreatic Cancer Stem Cell Maintenance and Can Be Used as a Functional Cancer Stem Cell Reporter , 2013, Stem cells translational medicine.

[40]  P. Dear,et al.  Genomic evidence of pre-invasive clonal expansion, dispersal and progression in bronchial dysplasia , 2011, The Journal of pathology.

[41]  Wolfgang Wagner,et al.  Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. , 2010, Genome research.

[42]  N. Ahuja,et al.  Aging, methylation and cancer. , 2000, Histology and histopathology.

[43]  L. Vinall,et al.  MUC7 Haplotype Analysis: Results from a Longitudinal Birth Cohort Support Protective Effect of the MUC7*5 Allele on Respiratory Function , 2006, Annals of human genetics.

[44]  A. Teschendorff,et al.  An Epigenetic Signature in Peripheral Blood Predicts Active Ovarian Cancer , 2009, PloS one.

[45]  Steven J. M. Jones,et al.  Integrated genomic characterization of endometrial carcinoma , 2013, Nature.

[46]  Alan D. Lopez,et al.  50-year trends in smoking-related mortality in the United States. , 2013, The New England journal of medicine.

[47]  A. Sheikh,et al.  Effect of smoke-free legislation on perinatal and child health: a systematic review and meta-analysis. , 2014, European journal of paediatric dentistry.

[48]  A. Feinberg,et al.  Large-scale hypomethylated blocks associated with Epstein-Barr virus–induced B-cell immortalization , 2014, Genome research.

[49]  Dirkje S Postma,et al.  Molecular signature of smoking in human lung tissues. , 2012, Cancer research.

[50]  H. Brenner,et al.  F2RL3 methylation in blood DNA is a strong predictor of mortality. , 2014, International journal of epidemiology.

[51]  L. Bystrykh,et al.  The Polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion. , 2006, Blood.

[52]  G. Warren,et al.  Active smoking and breast cancer risk: Original cohort data and meta-analysis: Gaudet MM, Gapstur SM, Sun J, et al (American Cancer Society, Atlanta, GA) J Natl Cancer Inst 105:515-525, 2013 , 2013 .